{"key":"mazdutide","slug":"mazdutide","name":"Mazdutide","other_names":[],"kind":"single","area":{"slug":"metabolic","name":"Metabolic"},"classification":"Dual GLP-1 and glucagon receptor agonist","standing":{"id":"phase-3","label":"Phase 3 trials","rank":4},"summary":"A once-weekly peptide that acts on the GLP-1 and glucagon receptors, studied in phase 3 trials in obesity and type 2 diabetes.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":58,"in_humans":38,"clinical_trials":9},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/mazdutide","article":null,"evidence":{"query":"(\"Mazdutide\"[tiab])","fetched_at":"2026-11-16T23:01:36.505Z","counts":{"rcts":9,"human":38,"total":58,"reviews":30,"clinicalTrials":9},"years":[{"year":2012,"count":0},{"year":2013,"count":0},{"year":2014,"count":0},{"year":2015,"count":0},{"year":2016,"count":0},{"year":2017,"count":0},{"year":2018,"count":0},{"year":2019,"count":0},{"year":2020,"count":0},{"year":2021,"count":0},{"year":2022,"count":1},{"year":2023,"count":1},{"year":2024,"count":8},{"year":2025,"count":20},{"year":2026,"count":34}],"top":[{"doi":"10.1136/bmj-2026-372161","url":"https://pubmed.ncbi.nlm.nih.gov/42419792/","kind":"review","pmid":"42419792","year":2026,"title":"Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis","venue":"BMJ (Clinical research ed.)","authors":"Nong K, Shi Q, Xie X, et al."},{"doi":"10.1056/NEJMoa2411528","url":"https://pubmed.ncbi.nlm.nih.gov/40421736/","kind":"rct","pmid":"40421736","year":2025,"title":"Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight","venue":"The New England journal of medicine","authors":"Ji L, Jiang H, Bi Y, et al."},{"doi":"10.1124/pharmrev.123.001045","url":"https://pubmed.ncbi.nlm.nih.gov/39952695/","kind":"review","pmid":"39952695","year":2025,"title":"Emerging pharmacotherapies for obesity: A systematic review","venue":"Pharmacological reviews","authors":"Kokkorakis M, Chakhtoura M, Rhayem C, et al."},{"doi":"10.3389/fendo.2024.1309118","url":"https://pubmed.ncbi.nlm.nih.gov/38440786/","kind":"meta","pmid":"38440786","year":2024,"title":"Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials","venue":"Frontiers in endocrinology","authors":"Nalisa DL, Cuboia N, Dyab E, et al."},{"doi":"10.1097/MJT.0000000000001756","url":"https://pubmed.ncbi.nlm.nih.gov/39292847/","kind":"meta","pmid":"39292847","year":2024,"title":"Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials","venue":"American journal of therapeutics","authors":"Ayesh H, Ayesh S, Niswender K"},{"doi":"10.1038/s41467-023-44067-4","url":"https://pubmed.ncbi.nlm.nih.gov/38092790/","kind":"rct","pmid":"38092790","year":2023,"title":"A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity","venue":"Nature communications","authors":"Ji L, Jiang H, Cheng Z, et al."},{"doi":"10.1007/s40265-025-02249-y","url":"https://pubmed.ncbi.nlm.nih.gov/41028652/","kind":"review","pmid":"41028652","year":2025,"title":"Mazdutide: First Approval","venue":"Drugs","authors":"Shirley M"},{"doi":"10.1038/s41586-025-10026-w","url":"https://pubmed.ncbi.nlm.nih.gov/41407859/","kind":"rct","pmid":"41407859","year":2026,"title":"Mazdutide versus placebo in Chinese adults with type 2 diabetes","venue":"Nature","authors":"Zhu D, Zhao J, Cai H, et al."},{"doi":"10.2337/dc23-1287","url":"https://pubmed.ncbi.nlm.nih.gov/37943529/","kind":"rct","pmid":"37943529","year":2024,"title":"Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial","venue":"Diabetes care","authors":"Zhang B, Cheng Z, Chen J, et al."},{"doi":"10.1038/s41586-025-10031-z","url":"https://pubmed.ncbi.nlm.nih.gov/41407860/","kind":"rct","pmid":"41407860","year":2026,"title":"Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes","venue":"Nature","authors":"Guo L, Zhang B, Xue X, et al."}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}